The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility

Brendan Elsworth1,2, Sida Ye1,3,4, Sheena Dass1

  • 1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Science (New York, N.Y.)
|February 6, 2025
PubMed

Insights

Combating malaria parasites like Plasmodium knowlesi is challenged by drug resistance. This study maps essential genes, revealing drug targets and resistance mechanisms to inform new antimalarial therapies.

Area of Science:

  • Malariology
  • Genomics
  • Drug Discovery

Background:

  • Antimalarial drug resistance threatens global health.
  • Limited drug options and emerging resistance necessitate new therapeutic strategies.
  • Understanding parasite genetics is crucial for identifying novel drug and vaccine targets.

Purpose of the Study:

  • To create a comprehensive gene essentiality map for Plasmodium knowlesi.
  • To identify conserved and divergent genetic elements across Plasmodium species.
  • To uncover modulators of artemisinin susceptibility in malaria parasites.

Main Methods:

  • Conducted a large-scale transposon mutagenesis screen in Plasmodium knowlesi.
  • Performed comparative genomic analysis of the druggable genome across Plasmodium species.
  • Utilized perturbation analyses with artemisinin to identify drug susceptibility modulators.

Main Results:

  • Generated the most complete gene essentiality classification for any Plasmodium species to date.
  • Identified conserved druggable genes and divergences in mitochondrial metabolism between Plasmodium species.
  • Discovered genetic modulators that influence susceptibility to the antimalarial artemisinin.

Conclusions:

  • Findings provide a foundation for prioritizing drug and vaccine targets, particularly for the Plasmodium vivax clade.
  • Elucidated mechanisms of antimalarial drug resistance, informing future therapeutic development.
  • The comprehensive gene map offers insights into Plasmodium biology and potential vulnerabilities.